Refresh Optive Mega-3 Solution/ Drops
NDC Package 0023-7151-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Refresh Optive Mega-3 (carboxymethylcellulose sodium, glycerin and polysorbate 80) solution/ dropses is to open, TWIST AND PULL TAB TO REMOVE. This formulation utilizes a solution/ drops delivery system. Marketed by Allergan, Inc., this product is identified by NDC 0023-7151 and is authorized under FDA application M018.

Identification & Billing

NDC Package Code
0023-7151-60
Package Description
60 VIAL, SINGLE-USE in 1 BOX / .4 mL in 1 VIAL, SINGLE-USE
Product Code
0023-7151
11-Digit Billing Format
00023715160
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1241471 - carboxymethylcellulose sodium 0.5 % / glycerin 1 % / polysorbate 80 0.5 % Ophthalmic Solution
  • RxCUI: 1241471 - carboxymethylcellulose sodium 5 MG/ML / glycerin 10 MG/ML / polysorbate 80 5 MG/ML Ophthalmic Solution

Clinical Specifications

Proprietary Name
Refresh Optive Mega-3
Non-Proprietary Name
Carboxymethylcellulose Sodium, Glycerin And Polysorbate 80
Substance Name
Carboxymethylcellulose Sodium; Glycerin; Polysorbate 80
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Pharmacologic Class
Usage Information
To open, TWIST AND PULL TAB TO REMOVE. Instill 1 or 2 drops in the affected eye(s) as needed and discard container.

Regulatory & Marketing

Labeler Name
Allergan, Inc.
Product Type
Human Otc Drug
FDA Application #
M018
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-15-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0023-7151-60 identifies a specific commercial package of 60 vial, single-use in 1 box / .4 ml in 1 vial, single-use of Refresh Optive Mega-3, a human over the counter drug labeled by Allergan, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This solution/ drops is formulated for ophthalmic use and contains carboxymethylcellulose sodium; glycerin; polysorbate 80 as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Allergan, Inc. on June 15, 2021. The current certification is valid through December 31, 2026.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00023715160. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0023-7151-60
11-Digit CMS (5-4-2)
00023-7151-60

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.